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Results

Introduction
Sound information begins from hair cells (HCs) in the
inner ear and travels to the brain through spiral ganglion
neurons (SGNs) (Figure 1). The peripheral processes of SGN
auditory nerve fibers (AFNs) extend toward the HCs and the
central processes of ANFs bifurcate and project into the cochlear
nucleus. The ascending branch goes into the anteroventral
cochlear nucleus (AVCN) and the descending branch extends
toward the dorsal cochlear nucleus (DCN) via the posteroventral
cochlear nucleus (PVCN). When SGN innervate neurons in the
DCN, the endings of SGN AFNs form a small button-like
synapse. In contrast to the DCN, the auditory nerve fibers
connect to the bushy cell neurons in the AVCN with an
extraordinary large synaptic ending called the Endbulb of Held.

Figure 2
Figure 7 Bifurcation and outgrowth of high- or low-frequency fibers in the CN. (A-H’)
Individual high- (tamoxifen on E9.5) or low-frequency (tamoxifen on E12.5) fibers (red) were
genetically labeled in vibratome sections from E13.5 to E17.5 Ngn1-CreERT2; Ai14 tdTomato
mice. Neurons were labeled by NeuN staining (green). (A-C and E-G) Branching of low-frequency
fibers is initiated two days later when compared to high-frequency fibers ( E15.5 v.s E13.5; white
arrows indicate two branches of AFNs). (D-D’ and H-H’) AFNs form axonal bundles (white
arrowheads) while innervating the CN subdivisions.
Figure 3 Genetic labeling of high- or low-frequency-responsive SGNs and their fibers. By treating
Ngn1-CreERT2;R26iAP mice with a single dose of tamoxifen on either E9.5 or E12.5, we can
respectively label the high- (tamoxifen on E9.5) or low-frequency (tamoxifen .on E12.5) SGNs and their
.
afferent fibers. Labeled neurons and fibers were revealed by staining of alkaline phosphatase
(AP)
activity in the cochlea. (A-B’) AP staining of apical or basal turns of P0 cochleae with tamoxifen on E9. 5
(A,A’) or E12.5 (B,B’). θ is the angular spread of AP staining in the cochlear turn. Green arrowhead
indicates that the labeled central fibers from the apical SGNs can be seen in the basal turn.

Figure 1 Schematic of auditory circuits in the cochlea and
the CN
In the cochlea and CN, SGN cell bodies and their auditory
nerve fibers, respectively, are also arranged in a tonotopic
gradient according to frequency responses and each of three
subdivisions of the CN is also tonotopically organized (Figure
2). SGNs responding to high frequency sounds are located at
the basal portion of the cochlea and project their fibers to dorsal
regions of the CN subdivisions, while SGNs that convey
information of low frequency sounds are located at the cochlear
apex and send their fibers to ventral portions of the CN
subdivisions, forming isofrequency bands where nearby neurons
in the CN have similar frequency responses. How SGNs that
respond to different sound frequencies innervate the CN to form
a tonotopic map have not yet fully understood. As defects of the
tonotopic map in central auditory circuits often result in central
auditory processing disorders (CAPDs).
Understanding the mechanism
of how functionally distinct
SGNs innervate the CN to
establish
a
tonotopic
organization will help us
uncover the causes and
pathogenesis of some CAPDs.
In this study, we use genetic
approaches to label functionally
distinct SGNs and their auditory
nerve fibers at different stages.
We found that SGNs with
distinct preferred frequency
responses employ different
strategies
to
target
and
innervate CN neurons during
tonotopic map formation.
Figure 2 The tonotopic maps
of the cochlea and the CN

Methods
SGNs originate from a neurogenic domain of the otic vesicle by
transiently expressing the transcription factor Neurogenin1
(Ngn1) in a basal to apical progression along the length of the
cochlea between E9.5 and E12.5 in mice (Koundakjian et al.,
2007). Therefore, a small subset of SGNs can be genetically
labeled using the Ngn1-CreERT2 mouse line and a Credependent reporter upon Cre induction by a single low dose
tamoxifen administration. This allows us to reproducibly label
SGNs and their ANFs that respond to different sound
frequencies by providing tamoxifen at a specific time point
between E9.5 (start of neurogenesis, label high-frequencyresponsive neurons and their fibers) and E12.5 (end of
neurogenesis, label low-frequency-responsive neurons and their
fibers) (Figure 2 and 3). Two Cre-dependent reporter mouse
lines were used. R26iAP Cre reporter expresses alkaline
phosphatase after Cre-mediated recombination and allows us to
examine overall innervation patterns of ANFs in the CN. Ai14
tdTomato Cre reporter expresses tdTomato red fluorescence
proteins after Cre-mediated recombination and allows us to
visualize individual ANFs and their synaptic endings.

Figure 3

Figure 4 Tonotopic innervation of high- or low-frequency fibers in the CN. (A-F’) Innervation of
high- (tamoxifen on E9.5) or low-frequency (tamoxifen on E12.5) fibers in the CN on E15.5 and P0 or
in three subdivisions of the CN on P20. Red dotted lines outline the CN or CN subdivisions (DCN,
PVCN, or AVCN). AP staining of CN sections revealed that afferent inputs from the cochlea were
tonotopically distinct by E15.5 (A,D), and high- or low-frequency fibers target dorsal or ventral portion
respectively in the CN subdivisions on P20 (C, C’, F, and F’). ChP: choroid plexus.

Figure 5 High- and low-frequency fibers show differential innervation patterns in the CN during
development. (A-H) Innervation of high- (tamoxifen on E9.5) and low-frequency (tamoxifen on E12.5)
fibers in the AVCN on P0, P5, P10, and P20. Red dotted lines outline the AVCN. High-frequency fibers
initially innervate a widespread area but later confine to a small region. In contrast, low-frequency fibers
are more accurate in initial targeting and stay in a small area from P0 to P20. ChP: choroid plexus.
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Figure 6 Quantification of normalized
surface fraction of AVCN innervated by APlabeled fibers (SAP/SAVCN). To normalize the
amount of SGN labeling between samples, we
measured the angular spread of AP staining
from the cochlear turn (θx) to be normalized
(e.g. Fig. 3A’ and B) and normalized this value
to the average angular spread of staining of all
cochlear turns (θav). High-frequency fibers
initially innervated ~68% AVCN surface area
(SAVCN) on P0 but gradually confined to ~16%
SAVCN by P20. In contrast, low-frequency fibers
underwent minimal target sampling, and the
percentage of SAVCN targeted by low-frequency
fibers refined only slightly from ~24% to ~13%
from P0 to P20. n= 3 animals per group per
age. ***: P<0.005. ns: not statistically
significant. Means ± SEMs are shown.

Figure 8 Synaptogenesis of
high- or low-frequency
fibers
in
the
CN
subdivision.
(A-H’)
Individual high- (tamoxifen on
E9.5)
or
low-frequency
(tamoxifen on E12.5) fiber
and its synaptic terminals
(red)
were
genetically
labeled in vibratome sections
from P0 to P20 Ngn1CreERT2; Ai14 tdTomato
mice. Neuron were counterstained by NeuN staining
(green). (A-H) Both high- and
low-frequency auditory nerve
endings in the AVCN initially
form puncta and small
swellings (white arrows in
P5) but progressively grows
to form a highly branched
and
intricate
endbulb
synaptic terminals (white
arrows in P10 and P20).
(A’-H’) Descending branches of high- and low-frequency fibers make standard boutons synaptic
endings in the DCN.
Figure
9
Endbulb
synaptic
terminals of high- or lowfrequency fibers in the AVCN. (AB) Individual high- (tamoxifen on
E9.5) or low-frequency (tamoxifen on
E12.5) fiber and its endbulb
terminals were genetically labeled in
vibratome sections from P20 Ngn1CreERT2; Ai14 tdTomato mice.
Postsynaptic bushy cells were
labeled by Nissl staining (green). (A’B’’) 3D reconstruction of Endbulbs of
Held (red) and bushy cells (green)
using Amira 3D software. Most highfrequency fibers terminated on bushy cells unbranchedly as a single large Endbulb of Held (Endbulb
size: 351 μm3 in A’), while a higher proportion of low-frequency fibers showed multiple terminal
branching and small Endbulb endings (white arrows; Endbulb size: 151 μm3 and 96 μm3 in B’).

Conclusions
Functionally distinct SGN populations employ different strategies to target and innervate CN
neurons during tonotopic map formation.
1. High-frequency fibers initially overshoot and sample a large area of different targets
before refining their connections to correct targets, while low-frequency SGNs are more
accurate in initial targeting and undergo minimal target sampling.
2. The central fibers of SGNs also show a gradient of development along the tonotopic
axis, with outgrowth and branching of high-frequency fibers initiate two days earlier than
the processes of low-frequency fibers.
3. The processes of synaptogenesis are similar between high- and low-frequency fibers
but a higher proportion of low-frequency fibers form smaller endbulb endings with
multiple terminal branching.
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